{
    "eid": "2-s2.0-85107251618",
    "title": "Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized Controlled Trial",
    "cover-date": "2021-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pediatrics, Perinatology and Child Health",
            "@code": "2735",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Obstetrics and Gynecology",
            "@code": "2729",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Latency period",
        "Micronized progesterone",
        "Preterm labor",
        "Supplementation",
        "Vagina"
    ],
    "authors": [
        "Ratanawadee Sirisangwon",
        "Vorapong Phupong"
    ],
    "citedby-count": 1,
    "ref-count": 21,
    "ref-list": [
        "ACOG practice bulletin no. 130: Prediction and prevention of preterm birth",
        "ACOG practice bulletin no. 171: Management of preterm labor",
        "A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor",
        "Progesterone use after successful treatment of threatened pre-term delivery",
        "Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor",
        "National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications",
        "Vaginal progesterone after tocolytic therapy in threatened preterm labor",
        "Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial",
        "Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study",
        "Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): Randomised double-blind placebo-controlled trial",
        "Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: A comparative study between vaginal and oral administration",
        "Endocrinology of human parturition: A review",
        "Control and assessment of the uterus and cervix during pregnancy and labour",
        "Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis",
        "Effects of vaginal progesterone for maintenance tocolysis on uterine electrical activity",
        "The use of micronized progesterone in the treatment of menace of preterm delivery",
        "Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: A multicentre, double-blind, randomised, placebo-controlled trial",
        "Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: A meta-analysis of individual patient data",
        "Maintenance therapy by vaginal progesterone after threatened idiopathic preterm labor: A randomized placebo-controlled double-blind trial",
        "Success rate of terbutaline in inhibiting preterm labor for 48 h"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}